Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Nakamura, Yoki ^a   Morioka, Norimitsu ^a   Abe, Hiromi ^a   Zhang, Fang Fang ^a   Hisaoka Nakashima, Kazue ^a   Liu, Keyue ^b   Nishibori, Masahiro ^b   Nakata, Yoshihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; MONOCLONAL ANTIBODY; PROTEIN C FOS; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ASTROCYTE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; GLIA CELL; HYPERSENSITIVITY; IMMUNOREACTIVITY; MALE; MICROGLIA; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; HMGB1 PROTEIN; INJECTIONS, INTRAVENOUS; NEURALGIA; RATS; SCIATIC NERVE;

EID: 84882609710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073640     Document Type: Article

References (39)

1. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ, (2002) HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72: 1084-1091.
2. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, et al. (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48: 971-981.
3. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
4. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ, (2000) HMG-1 as a mediator of acute lung inflammation. J Immunol 165: 2950-2954.
5. Andersson U, Tracey KJ, (2003) HMGB1 in sepsis. Scand J Infect Dis 35: 577-584.
6. Lo Coco D, Veglianese P, Allievi E, Bendotti C, (2007) Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS. Neurosci Lett 412: 73-77.
7. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, et al. (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 21: 3904-3916.
8. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, et al. (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26: 6413-6421.
9. Zhang J, Takahashi HK, Liu K, Wake H, Liu R, et al. (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42: 1420-1428.
10. Okuma Y, Liu K, Wake H, Zhang J, Maruo T, et al. (2012) Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann Neurol 72: 373-384.
11. Kanellakis P, Agrotis A, Kyaw TS, Koulis C, Ahrens I, et al. (2011) High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 31: 313-319.
12. Wang H, Li W, Goldstein R, Tracey KJ, Sama AE (2007) HMGB1 as a potential therapeutic target. Novartis Found Symp 280: 73-85; discussion 85-91, 160-164.
13. Feldman P, Due MR, Ripsch MS, Khanna R, White FA, (2012) The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain. J Neuroinflammation 9: 180.
14. Ren PC, Zhang Y, Zhang XD, An LJ, Lv HG, et al. (2012) High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes. Brain Res Bull 88: 332-337.
15. Shibasaki M, Sasaki M, Miura M, Mizukoshi K, Ueno H, et al. (2010) Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 149: 514-521.
16. Tong W, Wang W, Huang J, Ren N, Wu SX, et al. (2010) Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. Biochem Biophys Res Commun 395: 572-576.
17. Jha MK, Jeon S, Suk K, (2012) Glia as a Link between Neuroinflammation and Neuropathic Pain. Immune Netw 12: 41-47.
18. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B (2013) Importance of glial activation in neuropathic pain. Eur J Pharmacol.
19. Romero-Sandoval EA, Horvath RJ, DeLeo JA, (2008) Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs 9: 726-734.
20. Tsuda M, Masuda T, Tozaki-Saitoh H, Inoue K, (2013) Microglial regulation of neuropathic pain. J Pharmacol Sci 121: 89-94.
21. Nakagawa T, Kaneko S, (2010) Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 114: 347-353.
22. Tsuda M, Kohro Y, Yano T, Tsujikawa T, Kitano J, et al. (2011) JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain 134: 1127-1139.
23. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, et al. (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424: 778-783.
24. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, et al. (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438: 1017-1021.
25. Trang T, Beggs S, Wan X, Salter MW, (2009) P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 29: 3518-3528.
26. Xia M, Zhu Y, (2011) Signaling pathways of ATP-induced PGE2 release in spinal cord astrocytes are EGFR transactivation-dependent. Glia 59: 664-674.
27. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, et al. (2000) Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 75: 965-972.
28. Sheng W, Zong Y, Mohammad A, Ajit D, Cui J, et al. (2011) Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia. J Neuroinflammation 8: 121.
29. Seltzer Z, Dubner R, Shir Y, (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43: 205-218.
30. Echeverry S, Shi XQ, Rivest S, Zhang J, (2011) Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. J Neurosci 31: 10819-10828.
31. Beggs S, Liu XJ, Kwan C, Salter MW, (2010) Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Mol Pain 6: 74.
32. Youn JH, Shin JS, (2006) Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177: 7889-7897.
33. Lotze MT, Tracey KJ, (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
34. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A, (2008) HMGB1: endogenous danger signaling. Mol Med 14: 476-484.
35. Li Y, Ji A, Weihe E, Schäfer MK, (2004) Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. J Neurosci 24: 9623-9631.
36. Wang RK, Zhang QQ, Pan YD, Guo QL, (2013) Etanercept decreases HMGB1 expression in dorsal root ganglion neuron cells in a rat chronic constriction injury model. Exp Ther Med 5: 581-585.
37. Kim S, Kim SY, Pribis JP, Lotze M, Mollen KP, et al. (2013) Signaling of High Mobility Group Box 1 (HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD14. Mol Med.
38. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, et al. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 107: 11942-11947.
39. Leclerc P, Wähämaa H, Idborg H, Jakobsson P, Harris HE, et al. (2013) IL-1β/HMGB1 complexes promote the PGE2 biosynthesis pathway in synovial fibroblasts. Scand J Immunol.